CRISPR-based epigenetic editing of Gad1 improves synaptic inhibition and cognitive behavior in a Tauopathy mouse model

GABAergic signaling in the brain plays a key role in regulating synaptic transmission, neuronal excitability, and cognitive processes. Large-scale sequencing has revealed the diminished expression of GABA-related genes in Alzheimer's disease (AD), however, it is largely unclear about the epigen...

Full description

Saved in:
Bibliographic Details
Main Authors: Lei Wan, Ping Zhong, Pei Li, Yong Ren, Wei Wang, Mingjun Yu, Henry Y. Feng, Zhen Yan
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996125000427
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832542446537408512
author Lei Wan
Ping Zhong
Pei Li
Yong Ren
Wei Wang
Mingjun Yu
Henry Y. Feng
Zhen Yan
author_facet Lei Wan
Ping Zhong
Pei Li
Yong Ren
Wei Wang
Mingjun Yu
Henry Y. Feng
Zhen Yan
author_sort Lei Wan
collection DOAJ
description GABAergic signaling in the brain plays a key role in regulating synaptic transmission, neuronal excitability, and cognitive processes. Large-scale sequencing has revealed the diminished expression of GABA-related genes in Alzheimer's disease (AD), however, it is largely unclear about the epigenetic mechanisms that dysregulate the transcription of these genes in AD. We confirmed that GABA synthesizing enzymes, GAD1 and GAD2, were significantly downregulated in prefrontal cortex (PFC) of AD human postmortem tissues. A tauopathy mouse model also had the significantly reduced expression of GABA-related genes, as well as the diminished GABAergic synaptic transmission in PFC pyramidal neurons. To elevate endogenous Gad1 levels, we used the CRISPR/Cas9-based epigenome editing technology to recruit histone acetyltransferase p300 to Gad1. Cells transfected with a fusion protein consisting of the nuclease-null dCas9 protein and the catalytic core of p300 (dCas9p300), as well as a guide RNA targeting Gad1 promoter (gRNAGad1), had significantly increased Gad1 mRNA expression and histone acetylation at Gad1 promoter. Furthermore, the tauopathy mouse model with PFC injection of dCas9p300 and gRNAGad1 lentiviruses had significantly elevated GABAergic synaptic currents and improved spatial memory. These results have provided an epigenetic editing-based gene-targeting strategy to restore synaptic inhibition and cognitive function in AD and related disorders.
format Article
id doaj-art-66259939599849648c963f8611bd309f
institution Kabale University
issn 1095-953X
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj-art-66259939599849648c963f8611bd309f2025-02-04T04:10:18ZengElsevierNeurobiology of Disease1095-953X2025-03-01206106826CRISPR-based epigenetic editing of Gad1 improves synaptic inhibition and cognitive behavior in a Tauopathy mouse modelLei Wan0Ping Zhong1Pei Li2Yong Ren3Wei Wang4Mingjun Yu5Henry Y. Feng6Zhen Yan7Department of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14214, USADepartment of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14214, USADepartment of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14214, USADepartment of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14214, USADepartment of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14214, USADepartment of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14214, USADepartment of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14214, USACorresponding author at: State University of New York at Buffalo, 955 Main St., Buffalo, NY, USA.; Department of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14214, USAGABAergic signaling in the brain plays a key role in regulating synaptic transmission, neuronal excitability, and cognitive processes. Large-scale sequencing has revealed the diminished expression of GABA-related genes in Alzheimer's disease (AD), however, it is largely unclear about the epigenetic mechanisms that dysregulate the transcription of these genes in AD. We confirmed that GABA synthesizing enzymes, GAD1 and GAD2, were significantly downregulated in prefrontal cortex (PFC) of AD human postmortem tissues. A tauopathy mouse model also had the significantly reduced expression of GABA-related genes, as well as the diminished GABAergic synaptic transmission in PFC pyramidal neurons. To elevate endogenous Gad1 levels, we used the CRISPR/Cas9-based epigenome editing technology to recruit histone acetyltransferase p300 to Gad1. Cells transfected with a fusion protein consisting of the nuclease-null dCas9 protein and the catalytic core of p300 (dCas9p300), as well as a guide RNA targeting Gad1 promoter (gRNAGad1), had significantly increased Gad1 mRNA expression and histone acetylation at Gad1 promoter. Furthermore, the tauopathy mouse model with PFC injection of dCas9p300 and gRNAGad1 lentiviruses had significantly elevated GABAergic synaptic currents and improved spatial memory. These results have provided an epigenetic editing-based gene-targeting strategy to restore synaptic inhibition and cognitive function in AD and related disorders.http://www.sciencedirect.com/science/article/pii/S0969996125000427Alzheimer's diseaseGABAergic transmissionGAD1Histone acetylationCRISPRPrefrontal cortex
spellingShingle Lei Wan
Ping Zhong
Pei Li
Yong Ren
Wei Wang
Mingjun Yu
Henry Y. Feng
Zhen Yan
CRISPR-based epigenetic editing of Gad1 improves synaptic inhibition and cognitive behavior in a Tauopathy mouse model
Neurobiology of Disease
Alzheimer's disease
GABAergic transmission
GAD1
Histone acetylation
CRISPR
Prefrontal cortex
title CRISPR-based epigenetic editing of Gad1 improves synaptic inhibition and cognitive behavior in a Tauopathy mouse model
title_full CRISPR-based epigenetic editing of Gad1 improves synaptic inhibition and cognitive behavior in a Tauopathy mouse model
title_fullStr CRISPR-based epigenetic editing of Gad1 improves synaptic inhibition and cognitive behavior in a Tauopathy mouse model
title_full_unstemmed CRISPR-based epigenetic editing of Gad1 improves synaptic inhibition and cognitive behavior in a Tauopathy mouse model
title_short CRISPR-based epigenetic editing of Gad1 improves synaptic inhibition and cognitive behavior in a Tauopathy mouse model
title_sort crispr based epigenetic editing of gad1 improves synaptic inhibition and cognitive behavior in a tauopathy mouse model
topic Alzheimer's disease
GABAergic transmission
GAD1
Histone acetylation
CRISPR
Prefrontal cortex
url http://www.sciencedirect.com/science/article/pii/S0969996125000427
work_keys_str_mv AT leiwan crisprbasedepigeneticeditingofgad1improvessynapticinhibitionandcognitivebehaviorinatauopathymousemodel
AT pingzhong crisprbasedepigeneticeditingofgad1improvessynapticinhibitionandcognitivebehaviorinatauopathymousemodel
AT peili crisprbasedepigeneticeditingofgad1improvessynapticinhibitionandcognitivebehaviorinatauopathymousemodel
AT yongren crisprbasedepigeneticeditingofgad1improvessynapticinhibitionandcognitivebehaviorinatauopathymousemodel
AT weiwang crisprbasedepigeneticeditingofgad1improvessynapticinhibitionandcognitivebehaviorinatauopathymousemodel
AT mingjunyu crisprbasedepigeneticeditingofgad1improvessynapticinhibitionandcognitivebehaviorinatauopathymousemodel
AT henryyfeng crisprbasedepigeneticeditingofgad1improvessynapticinhibitionandcognitivebehaviorinatauopathymousemodel
AT zhenyan crisprbasedepigeneticeditingofgad1improvessynapticinhibitionandcognitivebehaviorinatauopathymousemodel